Lasdul (Duloxetine)

Duloxetine acts on serotonin and norepinephrine pathways and is indicated for several psychiatric and pain conditions.

• Major depressive disorder: reduces depressive symptoms and improves overall mood.
• Generalized anxiety disorder: alleviates excessive worry and anxiety.
• Diabetic peripheral neuropathic pain: lessens nerve‑related pain in diabetic patients.
• Fibromyalgia: decreases widespread musculoskeletal pain and fatigue.
• Chronic musculoskeletal pain: provides relief from persistent musculoskeletal discomfort.

• Duloxetine inhibits the reuptake of the neurotransmitters serotonin and norepinephrine at neuronal synapses, thereby increasing their extracellular concentrations. The enhanced serotonergic and noradrenergic signaling modulates pain pathways and mood regulation, contributing to its antidepressant, anxiolytic, and analgesic effects.

Duloxetine may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: transient stomach upset, often early in therapy.
• Dry mouth: reduced salivation causing discomfort.
• Dizziness: light‑headed sensation, especially when standing quickly.
• Somnolence: increased sleepiness or fatigue.

Serious or Rare Side Effects

• Suicidal thoughts: emergence of suicidal ideation, particularly in young adults.
• Serotonin syndrome: potentially life‑threatening condition with agitation, hyperthermia, and muscle rigidity.
• Severe liver injury: jaundice, dark urine, or elevated liver enzymes.
• Hyponatremia: low blood sodium causing confusion or seizures.
• Severe allergic reaction: rash, swelling, or difficulty breathing.

Before initiating therapy, clinicians should evaluate specific risk factors and monitor patients closely.

• Assess for suicidal ideation: monitor mood changes, especially during the first weeks.
• Evaluate liver function: avoid use in patients with significant hepatic impairment.
• Review concomitant serotonergic agents: increase risk of serotonin syndrome.
• Monitor blood pressure: duloxetine may cause modest elevations.
• Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Duloxetine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis and serotonin syndrome.
• Serotonergic antidepressants (e.g., SSRIs, tricyclics): heightened serotonin toxicity.
• Strong CYP1A2 inhibitors (e.g., fluvoxamine): may increase duloxetine plasma levels.

Moderate Interactions (Monitor Closely)

• CYP2D6 substrates (e.g., codeine, tamoxifen): duloxetine may reduce their effectiveness.
• Anticoagulants (e.g., warfarin): potential for increased bleeding risk.
• NSAIDs or antiplatelet agents: may augment gastrointestinal bleeding risk.